TBT BSN | Notification

Notification Detail :: G/TBT/N/MEX/526/Add.1

Notification No.

Notification Type

Notifying Member

Date of Notification

Final Date for Comments

Days to Final Date

Title

Modificación de Emergencia a la Norma Oficial Mexicana NOM-059-SSA1-2015, Buenas prácticas de fabricación de medicamentos, publicada el 5 de febrero de 2016.

Objective

Quality requirements (TBT); Protection of human health or safety (TBT)

Product Covered

Medicamentos (HS: 30.04)

Document Notification

Link to ePing

HSCODE

3004 - Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. goods of heading 3002, 3005 or 3006); 3004 - Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. goods of heading 3002, 3005 or 3006)

ICSCODE

11.120 - Pharmaceutics; 11.120 - Pharmaceutics

Keywords

Human health; Human health; E09. COVID-19 TBT

Specific Regions

Description

Se prorroga por un plazo de seis meses contados a partir del 24 de febrero de 2024 la vigencia de la Modificación de Emergencia a la Norma Oficial Mexicana NOM-059-SSA1-2015, Buenas prácticas de fabricación de medicamentos, publicada el 5 de febrero de 2016, publicada en el Diario Oficial de la Federación el 23 de agosto de 2023.

Notified Document

1:File here

Link to Notification

ES:File here

Status Active

No	#	Comment By	Title	Comment Date	File

Back

Notification Detail :: G/TBT/N/MEX/526/Add.1

Link to ePing

App Settings